World Wires · story 68223 · corroborated · 1 source(s)

Development of CYP8B1-specific inhibitors for metabolic diseases

Changes in bile acids (BAs) balance lead to various metabolic diseases, yet current treatment options targeting these changes remain severely limited. CYP8

Open in the desk

Coverage

• Development of CYP8B1-specific inhibitors for metabolic diseases bioRxiv (new preprints) · tier C · clear net · 2026-10-22 00:00 UTC

What this site indexes